Investigational Site Number : 1560014

Changsha 410008

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer Metastatic, Hemophilia

Studies at this site

• Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer — Stopped early
• Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IX — Running, not enrolling